Abstract
Depression is a frequent mental disorder with a substantial contribution to years lived with disability worldwide. In the search for new treatment targets, the immune system’s contribution to the pathogenesis of depression has received increased attention as immune activation has been associated with depression in various epidemiological and case-control studies. Epidemiological studies have shown that immune exposures such as severe infections and autoimmune disorders increase the risk of depression. Furthermore, immune system activation has been indicated in case-control studies of depression revealing higher levels of key pro-inflammatory cytokines among patients with depression than healthy controls, particularly in blood and to some extent in the cerebrospinal fluid. Moreover, brain imaging studies indicate increased microglial activity during depression, and gut microbiota studies have documented alterations of gut microbiota composition to be associated with depression. Based on findings from animal and human studies, several immune-mediated molecular mechanisms have been suggested to underlie the association between increased immunological activity and depression. However, the research is challenged by the heterogeneity of the depression diagnosis and – to some extent – the precision of currently available technology for immune biomarker quantification, particularly regarding the assessment of low-grade neuroinflammation. Nonetheless, an enhanced understanding of the complex interactions between the immune system and the brain in the context of depression could pave the way for precision medicine approaches with immune-modulating treatment as a promising additional option in the treatment of depression.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- BBB:
-
Blood-brain barrier
- CNS:
-
Central nervous system
- CRP:
-
C-reactive protein
- CSF:
-
Cerebrospinal fluid
- EBV:
-
Epstein–Barr virus
- HLA:
-
Human leukocyte antigen
- IgG:
-
Immunoglobulin G
- IL:
-
Interleukin
- NMDAR:
-
N-methyl-D-aspartate receptor
- NLRP3:
-
NOD-, LRR- and pyrin domain-containing protein 3
- TNF-ɑ:
-
Tumor necrosis factor-ɑ
- TSPO:
-
18-kDa translocator protein
- WCC:
-
White cell count
References
Abbott NJ, Rönnbäck L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7(1):41–53
Atzeni F, Masala IF, Bagnasco M, Lanata L, Mantelli F, Sarzi-Puttini P (2021) Comparison of efficacy of Ketoprofen and Ibuprofen in treating pain in patients with rheumatoid arthritis: a systematic review and meta-analysis. Pain Ther 10(1):577–588
Baumeister H, Parker G (2012) Meta-review of depressive subtyping models. J Affect Disord 139(2):126–140
Benros ME, Waltoft BL, Nordentoft M, Ostergaard SD, Eaton WW, Krogh J et al (2013) Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiat 70(8):812–820
Beurel E, Toups M, Nemeroff CB (2020) The bidirectional relationship of depression and inflammation: double trouble. Neuron 107(2):234–256
Bi Y, Shen J, Chen S-C, Chen J-X, Xia Y-P (2021) Prognostic value of neutrophil to lymphocyte ratio in acute ischemic stroke after reperfusion therapy. Sci Rep 11(1):6177
Bodis G, Toth V, Schwarting A (2018) Role of human leukocyte antigens (HLA) in autoimmune diseases. Methods Mol Biol 1802:11–29
Boku S, Nakagawa S, Toda H, Hishimoto A (2018) Neural basis of major depressive disorder: beyond monoamine hypothesis. Psychiatry Clin Neurosci 72(1):3–12
Bromet E, Andrade LH, Hwang I, Sampson NA, Alonso J, de Girolamo G et al (2011) Cross-national epidemiology of DSM-IV major depressive episode. BMC Med 9:90
Brown SJ, Huang X-F, Newell KA (2021) The kynurenine pathway in major depression: what we know and where to next. Neurosci Biobehav Rev 127:917–927
Carson MJ, Doose JM, Melchior B, Schmid CD, Ploix CC (2006) CNS immune privilege: hiding in plain sight. Immunol Rev 213:48–65
Chen P, Jiang T, Ouyang J, Chen Y (2009) Depression, another autoimmune disease from the view of autoantibodies. Med Hypotheses 73(4):508–509
Corriger A, Pickering G (2019) Ketamine and depression: a narrative review. Drug Des Devel Ther 13:3051–3067
Costerus JM, Brouwer MC, van de Beek D (2018) Technological advances and changing indications for lumbar puncture in neurological disorders. Lancet Neurol 17(3):268–278
Dahm L, Ott C, Steiner J, Stepniak B, Teegen B, Saschenbrecker S et al (2014) Seroprevalence of autoantibodies against brain antigens in health and disease. Ann Neurol 76(1):82–94
Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M et al (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7(12):1091–1098
Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10(1):63–74
Daneman R, Prat A (2015) The blood-brain barrier. Cold Spring Harb Perspect Biol 7(1):a020412
Desai MK, Brinton RD (2019) Autoimmune disease in women: endocrine transition and risk across the lifespan. Front Endocrinol (Lausanne) 10:265
DiSabato DJ, Quan N, Godbout JP (2016) Neuroinflammation: the devil is in the details. J Neurochem 139(Suppl 2):136–153
Ehrenreich H (2017) Autoantibodies against the N-methyl-d-aspartate receptor subunit NR1: untangling apparent inconsistencies for clinical practice. Front Immunol 8:181
Enache D, Pariante CM, Mondelli V (2019) Markers of central inflammation in major depressive disorder: a systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue. Brain Behav Immun 81:24–40
Endres D, Perlov E, Dersch R, Baumgartner A, Hottenrott T, Berger B et al (2016) Evidence of cerebrospinal fluid abnormalities in patients with depressive syndromes. J Affect Disord 198:178–184
Fan Y, Pedersen O (2021) Gut microbiota in human metabolic health and disease. Nat Rev Microbiol 19(1):55–71
Franceschini A, Capece M, Chiozzi P, Falzoni S, Sanz JM, Sarti AC et al (2015) The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein. FASEB J Off Publ Fed Am Soc Exp Biol 29(6):2450–2461
Gabay C (2006) Interleukin-6 and chronic inflammation. Arthritis Res Ther 8(Suppl 2):S3
Garrido-Mesa N, Zarzuelo A, Gálvez J (2013) Minocycline: far beyond an antibiotic. Br J Pharmacol 169(2):337–352
Goldsmith DR, Rapaport MH, Miller BJ (2016) A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry 21(12):1696–1709
Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D et al (2010) Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 10(12):835–844
Gronemann FH, Petersen J, Alulis S, Jensen KJ, Riise J, Ankarfeldt MZ et al (2021) Treatment patterns in patients with treatment-resistant depression in Danish patients with major depressive disorder. J Affect Disord 287:204–213
Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med
Haase S, Linker RA (2021) Inflammation in multiple sclerosis. Ther Adv Neurol Disord 14:17562864211007688
Hammer C, Stepniak B, Schneider A, Papiol S, Tantra M, Begemann M et al (2014) Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity. Mol Psychiatry 19(10):1143–1149
Hampel H, Kotter HU, Padberg F, Korschenhausen DA, Moller HJ (1999) Oligoclonal bands and blood--cerebrospinal-fluid barrier dysfunction in a subset of patients with Alzheimer disease: comparison with vascular dementia, major depression, and multiple sclerosis. Alzheimer Dis Assoc Disord 13(1):9–19
Hasselbalch IC, Søndergaard HB, Koch-Henriksen N, Olsson A, Ullum H, Sellebjerg F et al (2018) The neutrophil-to-lymphocyte ratio is associated with multiple sclerosis. Mult Scler J Exp Transl Clin 4(4):2055217318813183
Hattori K, Ota M, Sasayama D, Yoshida S, Matsumura R, Miyakawa T et al (2015) Increased cerebrospinal fluid fibrinogen in major depressive disorder. Sci Rep 5:11412
Hegen H, Auer M, Zeileis A, Deisenhammer F (2016) Upper reference limits for cerebrospinal fluid total protein and albumin quotient based on a large cohort of control patients: implications for increased clinical specificity. Clin Chem Lab Med 54(2):285–292
Herken J, Prüss H (2017) Red flags: clinical signs for identifying autoimmune encephalitis in psychiatric patients. Front Psych 8:25
Hillhouse TM, Porter JH (2015) A brief history of the development of antidepressant drugs: from monoamines to glutamate. Exp Clin Psychopharmacol 23(1):1–21
Horsdal HT, Köhler-Forsberg O, Benros ME, Gasse C (2017) C-reactive protein and white blood cell levels in schizophrenia, bipolar disorders and depression – associations with mortality and psychiatric outcomes: a population-based study. Eur Psychiatry 44:164–172
Howard DM, Adams MJ, Clarke T-K, Hafferty JD, Gibson J, Shirali M et al (2019) Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat Neurosci 22(3):343–352
Howren MB, Lamkin DM, Suls J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71(2):171–186
Kadry H, Noorani B, Cucullo L (2020) A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS 17(1):69
Kara SP, Altunan B, Unal A (2021) Investigation of the peripheral inflammation (neutrophil-lymphocyte ratio) in two neurodegenerative diseases of the central nervous system. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol:1–9
Kaufmann FN, Costa AP, Ghisleni G, Diaz AP, Rodrigues ALS, Peluffo H et al (2017) NLRP3 inflammasome-driven pathways in depression: clinical and preclinical findings. Brain Behav Immun 64:367–383
Kelley KW, Bluthé R-M, Dantzer R, Zhou J-H, Shen W-H, Johnson RW et al (2003) Cytokine-induced sickness behavior. Brain Behav Immun 17(Suppl 1):S112–S118
Kelley N, Jeltema D, Duan Y, He Y (2019) The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci 20(13)
Kendler KS, Gatz M, Gardner CO, Pedersen NL (2006) A Swedish national twin study of lifetime major depression. Am J Psychiatry 163(1):109–114
Kettenmann H, Kirchhoff F, Verkhratsky A (2013) Microglia: new roles for the synaptic stripper. Neuron 77(1):10–18
Kim K, Lee S-G, Kegelman TP, Su Z-Z, Das SK, Dash R et al (2011) Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. J Cell Physiol 226(10):2484–2493
Kohler CA, Freitas TH, Maes M, de Andrade NQ, Liu CS, Fernandes BS et al (2017) Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand 135(5):373–387
Köhler-Forsberg O, Buttenschøn HN, Tansey KE, Maier W, Hauser J, Dernovsek MZ et al (2017) Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression. Brain Behav Immun 62:344–350
Kohler-Forsberg O, Lydholm CN, Hjorthoj C, Nordentoft M, Mors O, Benros ME (2019) Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials. Acta Psychiatr Scand 139(5):404–419
Korszun A, Moskvina V, Brewster S, Craddock N, Ferrero F, Gill M et al (2004) Familiality of symptom dimensions in depression. Arch Gen Psychiatry 61(5):468–474
Kruse JL, Lapid MI, Lennon VA, Klein CJ, Toole OO, Pittock SJ et al (2015) Psychiatric autoimmunity: N-methyl-D-aspartate receptor IgG and beyond. Psychosomatics 56(3):227–241
Kuek A, Hazleman BL, Ostör AJK (2007) Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad Med J 83(978):251–260
Kunugi H, Hori H, Ogawa S (2015) Biochemical markers subtyping major depressive disorder. Psychiatry Clin Neurosci 69(10):597–608
Lang K, Prüss H (2017) Frequencies of neuronal autoantibodies in healthy controls: estimation of disease specificity. Neurol Neuroimmunol Neuroinflammation 4(5):e386
Lynch SV, Pedersen O (2016) The human intestinal microbiome in health and disease. N Engl J Med 375(24):2369–2379
Lynch CJ, Gunning FM, Liston C (2020) Causes and consequences of diagnostic heterogeneity in depression: paths to discovering novel biological depression subtypes. Biol Psychiatry 88(1):83–94
Mac Giollabhui N, Ng TH, Ellman LM, Alloy LB (2020) The longitudinal associations of inflammatory biomarkers and depression revisited: systematic review, meta-analysis, and meta-regression. Mol Psychiatry
Magyari M, Sorensen PS (2020) Comorbidity in multiple sclerosis. Front Neurol 11:851
Malhi GS, Mann JJ (2018) Depression. Lancet 392(10161):2299–2312
Mazza MG, Lucchi S, Tringali AGM, Rossetti A, Botti ER, Clerici M (2018) Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 84:229–236
Melief CJM (2021) Special review: the future of immunotherapy. Immunother Adv 1(1). https://doi.org/10.1093/immadv/ltaa005
Middleton J, Neil S, Wintle J, Clark-Lewis I, Moore H, Lam C et al (1997) Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91(3):385–395
Miller AH, Pariante CM (2020) Trial failures of anti-inflammatory drugs in depression. Lancet Psychiatry 7:837
Miller AH, Raison CL (2016) The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 16(1):22–34
Moldavski A, Wenz H, Lange BE, Rohleder C, Leweke FM (2021) Case report: severe adolescent major depressive syndrome turns out to be an unusual case of anti-NMDA receptor encephalitis, Frontiers in psychiatry, vol 12, p 679996
Moustafa AT, Moazzami M, Engel L, Bangert E, Hassanein M, Marzouk S et al (2020) Prevalence and metric of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis. Semin Arthritis Rheum 50(1):84–94
Mousten IV, Sørensen NV, Christensen RH, Benros M (2022) Cerebrospinal fluid biomarkers in patients with unipolar depression compared to healthy controls: a comprehensive systematic review and meta-analysis. JAMA Psychiat. [Epub ahead of print]
Nettis MA, Veronese M, Nikkheslat N, Mariani N, Lombardo G, Sforzini L et al (2020) PET imaging shows no changes in TSPO brain density after IFN-α immune challenge in healthy human volunteers. Transl Psychiatry 10(1):89
Nikolova VL, Smith MRB, Hall LJ, Cleare AJ, Stone JM, Young AH (2021) Perturbations in gut microbiota composition in psychiatric disorders: a review and meta-analysis. JAMA Psychiat
Nudel R, Benros ME, Krebs MD, Allesøe RL, Lemvigh CK, Bybjerg-Grauholm J et al (2019) Immunity and mental illness: findings from a Danish population-based immunogenetic study of seven psychiatric and neurodevelopmental disorders. Eur J Hum Genet 27(9):1445–1455
Omori W, Hattori K, Kajitani N, Tsuchioka MO, Boku S, Kunugi H et al (2020) Increased matrix metalloproteinases in cerebrospinal fluids of patients with major depressive disorder and schizophrenia. Int J Neuropsychopharmacol 23(11):713–720
Orlovska-waast S, Köhler-forsberg O, Wiben S, Merete B, Kondziella D, Krogh J et al (2019) Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis. Mol Psychiatry 24:869–887
Osimo EF, Pillinger T, Rodriguez IM, Khandaker GM, Pariante CM, Howes OD (2020) Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls. Brain Behav Immun 87:901–909
Ousman SS, Kubes P (2012) Immune surveillance in the central nervous system. Nat Neurosci 15(8):1096–1101
Pollak TA, Lennox BR, Müller S, Benros ME, Prüss H, Tebartz van Elst L et al (2020) Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. The lancet. Psychiatry 7(1):93–108
Ransohoff RM (2016) How neuroinflammation contributes to neurodegeneration. Science 353(6301):777–783
Rea TD, Russo JE, Katon W, Ashley RL, Buchwald DS (2001) Prospective study of the natural history of infectious mononucleosis caused by Epstein-Barr virus. J Am Board Fam Pract 14(4):234–242
Restrepo-Martinez M, Ramirez-Bermudez J, Bayliss L, Espinola-Nadurille M (2020) Characterisation and outcome of neuropsychiatric symptoms in patients with anti-NMDAR encephalitis. Acta Neuropsychiatr 32(2):92–98
Ripke S, Wray NR, Lewis CM, Hamilton SP, Weissman MM, Breen G et al (2013) A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry 18(4):497–511
Rose NR (2017) Autoimmune diseases. In: Quah SR (ed) International encyclopedia of public health, 2nd edn. Academic Press, Oxford, pp 192–195. https://www.sciencedirect.com/science/article/pii/B9780128036785000291
Savitz J (2020) The kynurenine pathway: a finger in every pie. Mol Psychiatry 25(1):131–147
Shi K, Tian D-C, Li Z-G, Ducruet AF, Lawton MT, Shi F-D (2019) Global brain inflammation in stroke. Lancet Neurol 18(11):1058–1066
Simonsen CS, Flemmen HØ, Lauritzen T, Berg-Hansen P, Moen SM, Celius EG (2020) The diagnostic value of IgG index versus oligoclonal bands in cerebrospinal fluid of patients with multiple sclerosis. Mult Scler J Exp Transl Clin 6(1):2055217319901291
Sørensen NV, Orlovska-Waast S, Jeppesen R, Klein-Petersen AW, Christensen RH, Benros ME (2022) Neuroinflammatory biomarkers in the cerebrospinal fluid from 106 patients with recent onset depression compared to 106 individually matched healthy controls. Biol Psychiatry. [Epub ahead of print]
Spencer et al (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet 392(10159):1789–1858
Sproston NR, Ashworth JJ (2018) Role of C-reactive protein at sites of inflammation and infection. Front Immunol 9:754
Steiner J, Teegen B, Schiltz K, Bernstein H-G, Stoecker W, Bogerts B (2014) Prevalence of N-methyl-D-aspartate receptor autoantibodies in the peripheral blood: healthy control samples revisited. JAMA Psychiat 71(7):838–839
Streit WJ, Mrak RE, Griffin WST (2004) Microglia and neuroinflammation: a pathological perspective. J Neuroinflammation 1(1):14
Tanaka T, Narazaki M, Kishimoto T (2014) IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol 6(10):a016295
Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ (2021) 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 8(5):416–427
Torres-Aguilar H, Sosa-Luis SA, Aguilar-Ruiz SR (2019) Infections as triggers of flares in systemic autoimmune diseases: novel innate immunity mechanisms. Curr Opin Rheumatol 31(5):525–531
Troubat R, Barone P, Leman S, Desmidt T, Cressant A, Atanasova B et al (2020) Neuroinflammation and depression: a review. Eur J Neurosci
Turkheimer FE, Rizzo G, Bloomfield PS, Howes O, Zanotti-Fregonara P, Bertoldo A et al (2015) The methodology of TSPO imaging with positron emission tomography. Biochem Soc Trans 43(4):586–592. https://doi.org/10.1042/BST20150058
Valkanova V, Ebmeier KP, Allan CL (2013) CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord 150(3):736–744
Varatharaj A, Galea I (2017) The blood-brain barrier in systemic inflammation. Brain Behav Immun 60:1–12
Varfolomeev E, Vucic D (2018) Intracellular regulation of TNF activity in health and disease. Cytokine 101:26–32
Vindegaard N, Benros ME (2020) COVID-19 pandemic and mental health consequences: systematic review of the current evidence. Brain Behav Immun 89:531–542
Vindegaard N, Speyer H, Nordentoft M, Rasmussen S, Benros ME (2020) Gut microbial changes of patients with psychotic and affective disorders: a systematic review. Schizophr Res
Vindegaard N, Petersen LV, Lyng-Rasmussen BI, Dalsgaard S, Benros ME (2021) Infectious mononucleosis as a risk factor for depression: a nationwide cohort study. Brain Behav Immun 94:259–265
Visentin APV, Colombo R, Scotton E, Fracasso DS, da Rosa AR, Branco CS et al (2020) Targeting inflammatory-mitochondrial response in major depression: current evidence and further challenges. Oxid Med Cell Longev 2020:2972968
Wang X, Zhang L, Lei Y, Liu X, Zhou X, Liu Y et al (2014) Meta-analysis of infectious agents and depression. Sci Rep 4:4530
Wang L, Wang F-S, Gershwin ME (2015) Human autoimmune diseases: a comprehensive update. J Intern Med 278(4):369–395
Wei YB, Liu JJ, Villaescusa JC, Åberg E, Brené S, Wegener G et al (2016) Elevation of Il6 is associated with disturbed let-7 biogenesis in a genetic model of depression. Transl Psychiatry 6(8):e869
Willner P, Scheel-Krüger J, Belzung C (2013) The neurobiology of depression and antidepressant action. Neurosci Biobehav Rev 37(10 Pt 1):2331–2371
Wingo TS, Liu Y, Gerasimov ES, Gockley J, Logsdon BA, Duong DM et al (2021) Brain proteome-wide association study implicates novel proteins in depression pathogenesis. Nat Neurosci 24(6):810–817
Wium-Andersen MK, Ørsted DD, Nielsen SF, Nordestgaard BG (2013) Elevated C-reactive protein levels, psychological distress, and depression in 73, 131 individuals. JAMA Psychiat 70(2):176–184
Wray NR, Ripke S, Mattheisen M, Trzaskowski M, Byrne EM, Abdellaoui A et al (2018) Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet 50(5):668–681
Yang J, Zheng P, Li Y, Wu J, Tan X, Zhou J et al (2020) Landscapes of bacterial and metabolic signatures and their interaction in major depressive disorders. Sci Adv 6(49)
Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A et al (2001) The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 15(3):199–226
Acknowledgments
The present work was funded by an unrestricted grant from The Lundbeck Foundation (grant number R268-2016-3925).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sørensen, N.V., Benros, M.E. (2022). The Immune System and Depression: From Epidemiological to Clinical Evidence. In: Savitz, J., Yolken, R.H. (eds) Microorganisms and Mental Health. Current Topics in Behavioral Neurosciences, vol 61. Springer, Cham. https://doi.org/10.1007/7854_2022_369
Download citation
DOI: https://doi.org/10.1007/7854_2022_369
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-24332-5
Online ISBN: 978-3-031-24333-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)